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Abstract: European beech (Fagus sylvatica L.) is a deciduous tree, widely distributed in Europe and
largely appreciated for its wood and nutritive nuts. Beech leaf also enjoys food use as salad, but an
understanding of its nutraceutical value is still far from being achieved. Indeed, and also taking into
account beech leaf as a consistent biomass residue available beechwood production and use, it needs
to be explored as a valuable renewable specialized source of bioactive molecules. In this context, an
untargeted ultra-high-performance liquid chromatography hyphenated with high resolution mass
spectrometry (UHPLC-HRMS) approach was favorably applied to a beech leaf alcoholic extract,
which also was evaluated for its antiradical capability (by means of assays based on 2,2-diphenyl-1-
picrylhydrazyl (DPPH) and [2,2’-azinobis-(3-ethylbenzothiazolin-6-sulfonic acid)] (ABTS) radical
cation) and its ferric ion reducing power. Redox mitochondrial activity towards Caco-2 cells paved
the way to explore the extract’s capability to inhibit intracellular Reactive Oxygen Species (ROS)
using 2’,7’dichlorofluorescin diacetate (DCFH-DA) assay. Hydroxycinnamoyl derivatives, mainly
belonging to the chlorogenic acid class, and flavonoids were the main constituents. Uncommon
flavanone C-glycosides were also found, together with a plentiful flavonol diversity. Cell-free and
cell-based assays highlight its dose-dependent antioxidant efficacy, providing a foundation for further
investigation of beech leaf constituents and its valorization and use as a reservoir of bioactive natural
products with potential nutraceutical applications.
Keywords: Fagus sylvatica L.; beech leaf; ultra-high-pressure liquid chromatography electroSpray
ionization quadrupole time-of-flight mass spectrometry (UHPLC-ESI-QqTOF HRMS) analysis; an-
tioxidant assays; polyphenol recovery
1. Introduction
Nowadays, the replacement of synthetic and artificial chemicals with natural products
with less impact on human or animal health and environment, makes their recovery a
major challenge. Indeed, great efforts have been devoted to the discovery and exploitation
of renewable sources of valuable bioactive compounds, such as the so-called bioactive
specialized natural products. These latter include a number of compound classes and
sub-classes that, in the last years, have attracted a lot of attention for a possible application
in various sectors (i.e., nutri-cosmeceutical, medical and pharmacological), due to their
recognized benefits for human and animal health [1]. Thus, the research and valorization
of new plant matrices, also those not directly used for these purposes, need to be explored
as a virtuous source of these molecules. Innovative examples are agro-food wastes [2–4],
or biorefining of forest biomass [5], from which compounds with traditional use in the
prevention and/or treatment of different diseases could be favorably isolated [6]. By-
products from forestry and wood processing industry are promising feedstocks for the
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extraction of polyphenols, including tannins and other antioxidants [7]. Thus, the self-
renewal of plant matrices such as the deciduous leaves of forest or ornamental trees, could
be an alternative reservoir of compounds, exploitable for different useful applications.
Among forest trees, the Fagaceae family includes more than 900 species belonging to
8–10 genera, among which only Castanea, Fagus and Quercus are distributed in Asia, Europe
and North America. In particular, Fagus sylvatica L., known as common or European beech,
is an economically important tree species. It is widely distributed, from Northern Spain to
Southern Italy and the North of Greece in the South Europe up to Southern Scandinavia in
the North, and from the Atlantic Ocean in the West to the Black Sea in the East.
F. sylvatica leaves, as well as those of other forest trees, played an important role in
winter-feeding of livestock in Europe even after haymaking replaced leaf-fodder harvesting
over time. Indeed, different organs of Fagus sylvatica could be used as source of several
natural products [8]. Thus, while beech bark and wood could be a source of different
polyphenols [9], the fruits, named beechnuts, are used to obtain an oil rich in oleic and
linoleic acids, as well as in γ- and δ-tocopherols [10]. Unlike wood, beechnuts or bark,
whose chemical composition was rather well studied, there is very little literature data on
the chemical composition of the leaves [11], which comprises phenols and polyphenols
such as flavonoids, hydroxycinnamic acids and procyanidins [8,12], and triterpenes, such as
glycosylated oleanane-type saponins [13]. Leaf ethanolic extracts showed antimicrobial
activity [14], gastroprotective effects [15], with efficacy against Helicobacter pylori, and anti-
proliferative properties [16]. Beyond their chemical composition and biological activity,
leaves are considered an index to evaluate environmental pollution and defensive mecha-
nism to stress [17]. In the light of the above, the main objective of this study was to gain
deep insights into the polyphenol composition of F. sylvatica leaves, in order to show the
potential of their exploitation to obtain bioactive molecules. For this purpose, an untargeted
UHPLC-HRMS (Ultra-High-Performance Liquid Chromatography-High-Resolution Mass
Spectrometry) approach was applied to a methanolic leaf extract. The determination of
total phenols and flavonoids, as well as the antiradical and reducing activity of the extract
was also assessed, while its ability to slow down intracellular reactive oxygen species (ROS)
formation was preliminarily investigated in Caco-2 cells.
2. Materials and Methods
2.1. Plant Collection and Extraction
Fagus sylvatica leaves were collected in June 2017 in the Tannenberger Gehölz (Kiel,
Schleswig-Holstein, Germany, N 54◦21′52.6′′, E 10◦06′35.9′′, 25 m a. m. s. l., Google Earth).
In particular, leaves harvested between ca. 0.5 and 2 m above ground were collected
from six individual trees of various ages. The month average precipitation was 5 mm
and average temperature was 21–10 ◦C (max–min). Voucher specimens were deposited
in the herbarium of Kiel University (KIEL, Schleswig-Holstein Land, Germany) and the
private herbarium of Christian Zidorn (voucher code: FS_20160705A-1). Air-dried leaves
(240 g) were shredded, and then extracted by maceration in methanol overnight, followed
by an ultrasound accelerated maceration step (UAM; BransonicTM M3800-E, Branson
UltrasonicsTM, Danbury, CT, USA) (three sonication cycles, 35 min each). The alcoholic
extract was stored at −20 ◦C until use.
2.2. UHPLC-HRMS and MS/MS Parameters
The alcoholic extract was investigated using a NEXERA UHPLC system (Shimadzu,
Tokyo, Japan) equipped with a Luna® Omega C-18 column (50 × 2.1 mm i.d., 1.6 µm
particle size). Two µL of the sample were injected. The mobile phase was constituted by
water (solvent A) and acetonitrile (solvent B), both acidified with formic acid (0.1% v/v).
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A linear gradient was used, in which the percentage of solvent B increased as follows:
0–5 min, 5%→15% B; 5–10 min, 15% B; 10–12 min, 15%→17.5% B; 12–17 min, 17.5%→45%B;
17–18.50 min, 45% B; 18.51–20 min, column re-equilibration. The flow rate was set at
400 µL/min.
High-Resolution Mass Spectrometry (HR-MS) data were obtained by an AB SCIEX
Triple TOF® 4600 mass spectrometer (AB Sciex, Concord, ON, Canada), equipped with
a DuoSprayTM ion source (AB Sciex, Concord, ON, Canada) operating in the negative
ElectroSpray (ESI) mode. A full scan Time-Of-Flight (TOF) survey (accumulation time
100 ms, 100–1000 Da) and 8 information-dependent acquisition MS/MS scans (accumula-
tion time 50 ms, 80–850 Da) were acquired, using the following parameters: curtain gas
35 psi, nebulizer and heated gases 60 psi, ion spray voltage 4500 V, ion source temper-
ature 600 ◦C, declustering potential −70 V, collision energy −35 ± 5 V. The instrument
was controlled by Analyst® TF 1.7 software (AB Sciex, Concord, ON, Canada), whereas
MS data were processed by PeakView® software version 2.2 (AB Sciex, Concord, ON,
Canada). The compounds were identified mainly through the study of their tandem mass
spectrometry (TOF-MS/MS) fragmentation patterns, and the comparison with literature
data whenever possible.
2.3. Radical Scavenging Capacity: DPPH and ABTS Tests
Leaf alcoholic extract was tested at 200, 100, 50, 25, 12.5, 6.25, and 3.125 µg/mL (final
concentration levels) towards ABTS [2,2′-azinobis-(3-ethylbenzothiazolin-6-sulfonic acid)]
radical cation and 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical.
ABTS radical cation was generated as previously reported [18]. The ABTS•+ solution
was diluted with Phosphate-buffered saline (PBS; pH 7.4) until an absorbance of 0.7 at
734 nm was read. The extract at different doses was directly dissolved in the ABTS•+
solution, and after 6 min the absorbance was measured by a Victor3 spectrophotometer
(Perkin Elmer/Wallac, Waltham, MA, USA) in reference to a blank, in which the samples
were replaced with solvent [18].
DPPH• scavenging capability was estimated as previously reported [18], and the ab-
sorption at 517 nm was measured on the Victor3 spectrophotometer (Perkin Elmer/Wallac,
Waltham, MA, USA) in reference to a blank, in which the samples were replaced with
the solvent.
Trolox (4, 8, 16, 32 µM) was used as positive standard, and Trolox Equivalent Antioxi-
dant Capacity (TEAC) of beech-leaf extract was calculated, based on both ABTS and DPPH
tests. For each antiradical test, three replicate measurements for three samples (n = 3) of
the extract (in total, 3 × 3 measurements) were performed. All data were expressed as
mean ± standard deviation (SD).
2.4. Fe(III) Reducing Power
Beech leaf alcoholic extract (at 200, 100, 50, 25, 12.5, 6.25, and 3.125 µg/mL final con-
centration levels) was investigated for its ability to reduce the Fe3+ using ferricyanide FRAP
assay, as previously reported [19]. The absorbance was measured at 700 nm. The increase
in absorbance with reference to the blank was considered to value the reducing power.
Trolox (4, 8, 16, 32 µM) was used as positive standard, and TEAC value of beech-leaf extract
was calculated. The test was carried out performing three replicate measurements for three
samples (n = 3) of the extract (in total, 3 × 3 measurements). All data were expressed as
mean ± standard deviation (SD).
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2.5. Determination of Total Phenols
Total phenol content was determined according to the Folin-Ciocalteau procedure [19].
Samples (0.25 mg and 0.125 mg) were mixed with 2.25 mL of Na2CO3 (7.5% w/v) and
0.25 mL of Folin-Ciocalteu reagent. The tubes were mixed and allowed to stand for 3 h at
room temperature. The absorbance was read at 765 nm using a Synergy spectrophotometer
(Biotek, Winooski, VT, USA). The test was carried out performing three replicate measure-
ments for three samples (n = 3) of the extract (in total, 3 × 3 measurements). Data were
expressed as milligrams of gallic acid equivalents (GAEs) per g of extract (mean± standard
deviation). To this purpose, a gallic acid calibration curve (R2 = 0.9716) was built up in the
range 0.78–25 µg/mL (final concentration levels).
2.6. Determination of Total Flavonoids
The extract (0.5 mL) was dissolved in distilled water (5 mL), and NaNO2 solution
(5%, w/v; 0.3 mL) was added. After 5 min, AlCl3 solution (10%, w/v; 0.6 mL) was poured
into the flask, and after 6 min, NaOH solution (1.0 M; 2.0 mL) and distilled water (2.1 mL)
were added. The absorbance was read at 510 nm against the blank (water), and flavonoid
content is expressed as milligrams of quercetin equivalents per 100 g of fresh material [20].
To this purpose, a quercetin calibration curve (R2 = 0.9979) was built up in the range
0.78–100 µg/mL (final concentration levels). The test was carried out performing three
replicate measurements for three samples (n = 3) of the extract (in total, 3 × 3 measure-
ments). All data were expressed as mean ± standard deviation (SD).
2.7. Cell Culture, Cytotoxicity and Intracellular ROS Assessment
Human epithelial cell line Caco-2 (ATCC® HTB¬37™, American Type Culture, Man-
assas, VA, USA) was cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) sup-
plemented with 10% fetal bovine serum, 50.0 U/mL of penicillin and 100.0 µg/mL of
streptomycin, at 37 ◦C in a humidified atmosphere containing 5% CO2. Cells were seeded
in 96-multiwell plates at a density of 2.5 × 104 cells/well. After 24 h, cells were treated for
24 h with different doses of the beech leaf alcoholic extract (25, 50, 100 and 200 µg/mL) or
pure quercetin standard (5, 10, and 50 µM). When incubation was completed, inhibition
of mitochondrial redox activity was determined by the MTT cell viability test, which was
based on the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) dye,
as previously described [3,4]. In order to evaluate intracellular ROS inhibition [21], Caco-2
cells were seeded at a density of 2.5 × 104 well on a black 96-well microplate in 100 µL
growth medium/well. Cells were cultured for 24 h at 37 ◦C in 5% CO2 and observed under
the inverted phase contrast microscope. After 24 h, the growth medium was removed, and
cells were twice washed with PBS (100 µL). Then, the cells were co-exposed to the inves-
tigated extract (25, 50, 100 and 200.0 µg/mL; final concentration levels) or quercetin (10
µM) and 2′,7′-dichlorofluorescin diacetate (DCFH-DA; 60 µM) for 60 min. The treatment
medium was then removed, the cells were washed with PBS, and 2,2′-azobis(2-methyl
propionamidine)dihydrochloride (AAPH, 500 µM; 100 µL) was added. The 96-well mi-
croplate was placed into a PerkinElmer Victor3 Multilabel Plate Reader at 37 ◦C. The
fluorescence intensity was measured at 485 nm excitation and 535 nm emission wavelength
every 20 min for 100 min. Two independent experiments were carried out performing
in each six replicate measurements for three samples (n = 3) of the extract (in total, 6 × 3
measurements). Data were expressed as mean ± standard deviation (SD).
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3. Results and Discussion
3.1. Chemical Composition of F. sylvatica Leaf Methanolic Extract
Nowadays, the growing consciousness of environmental sustainability promotes
the recovery of waste from production chains, also as basis and foundation of a circular
economy. Renewable forest materials are rich in nutrients and bioactive molecules, whose
recovery opens up to the development of functional products with high added value [22],
to be used in various production sectors, from food, to nutraceuticals, cosmetics, up to
the creation of packaging. In this context, getting insight into the chemical composition of
beech leaf, its diversity in polyphenols could represent its intrinsic value.
The analytical determination of the diversity in bioactive molecules, after suitable ex-
traction of the matrix, represents the crucial step of the entire process. Actually, techniques
in tandem mass spectrometry hyphenated with chromatographic separation methods al-
lows the chemical composition to be finely unraveled through an untargeted approach that
provides accuracy in phenolomic data and compounds identification [23].
In the present study UHPLC-ESI-HRMS and High-Resolution tandem mass spec-
trometry (HR-MS/MS) techniques were first applied to unravel the chemical composition
of this undervalued plant source [24–26]. An untargeted metabolic approach was used.
Sixty-nine compounds were tentatively identified (Figure 1), mainly belonging to phenol
and polyphenol classes. These latter have been described also as constituents of other
forest trees and their wastes. Indeed, recently, bulk samples of bark waste from Pinus
contorta, Pinus sylvestris, and Quercus robur, were investigated in depth for their polyphenol
content [27], and various biomass residues (shavings, edged cuts, and pruning wastes)
from walnut were analyzed as sources of antioxidant compounds by means of a green
extraction process [28]. In this context, Pycnogenol® (PYC) and Flavangenol® are good
examples of commercially available pine bark-based products [29]. The bark of douglas fir
(Pseudotsuga menziesii Franco), one of the premier timber trees in the world, was found a
rich source in taxifolin, which is broadly applied in pharmaceutical preparations [30].
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In Table 1, ESI negative ion mode MS and MS/MS data, molecular formulas, unsatu-
ration degree (RDB-Ring and Double Bond) values and mass accuracy are listed.
3.1.1. Benzoic and Hydroxycinnamic Acids Derivatives
Compounds 4, 5 and 6 were tentatively identified as (di)hydroxybenzoic acid hexo-
sides and dihydroxybenzoic acid, respectively. In fact, deprotonated glycosides underwent
homolytic and heterolytic cleavages of the hexose moiety, providing fragment ions at m/z
153.0191 and m/z 152.0112.
Compounds 7 and 16, previously identified in F. sylvatica leaves, were tentatively iden-
tified, in a ratio 1:2, as 3-O- and 5-O-caffeoyl quinic acid (Figure 2, panels A and B) based on
the elution order and different fragmentation patterns [31]. The fragment ion at m/z 179.03
(deprotonated caffeic acid) was also identified in TOF-MS/MS spectra of compounds 8
(at m/z 341.0879), 9 (at m/z 297.0613) and 17 (at m/z 253.0718), which were tentatively
identified as caffeoyl acid hexoside (C15H18O9), caffeoyl threonic acid (C13H14O8) and
caffeoyl propanoic acid (C12H14O6), respectively. The fragmentation pattern of metabolite
9 showed also product ions at m/z 135.0304 and m/z 117.0192 (Figure 2D), corresponding
to deprotonated threonic acid and its dehydrated derivative. Instead, for metabolite 17 the
propionyl moiety (C3H6O2) was identified by neutral loss of 74.04 Da (Figure 2E). Other
caffeoyl derivatives were the metabolites 3, tentatively identified as hydroxycaffeoyl quinic
acid, and 12, that putatively corresponded to a dimer of caffeoyl quinic acid. In particular,
in the TOF-MS/MS spectrum of metabolite 3, whose isomer, with antimicrobial activity
against Staphylococcus aureus and Escherichia coli, was isolated from Hymenocrater calycinus
(Boiss.) Benth. [32], the deprotonated molecular ion at m/z 371.1052 underwent neutral
loss of 18 Da, providing the less intense ion at m/z 353.0872 (caffeoyl quinate), and gave
rise to the abundant ion at m/z 191.0554 (quinate) (Figure 2F). Deprotonated molecular ion
of metabolite 12, at m/z 707.1845, underwent neutral loss of 174 Da and 192 Da, whose
presence was further confirmed by fragment ion at m/z 191.0557. Moreover, according to
TOF-MS/MS spectrum, the ring arrangement could be of the β-truxillic acid type; cleavages
along the two axes of central core provided the fragment ions at m/z 463.1085, 353.0870
and 243.0651 (Figure S1).
Furthermore, coumaroyl derivatives were also identified: compounds 11 and 20,
at m/z 337.0921(18), were tentatively identified as 3-O- and 5-O-p-coumaroyl quinic acid
(pCoQAs) in accordance with the molecular formula C16H18O9 (Figure 2,panels G and H),
whereas compound 14, showing the [M−H]− ion at m/z 325.0921, was tentatively identified
as p-coumaroyl hexoside (Figure 2I). In all TOF-MS/MS spectra, the fragment ion at m/z
163.04 was detected, highlighting the presence of deprotonated coumaric acid (C9H8O3).
Compounds 21 and 22, whose deprotonated molecular ion was in accordance with the
molecular formula C16H16O8, could be caffeoylshikimic acids (CSAs) [31]. Both metabolites
showed fragment ions at m/z 179.03 and 161.02, generated by neutral loss of 156 Da
(shikimic acid-H2O) and 174 Da (shikimic acid) (Figure 2, panels J and K). The intensity of
this latter allowed us to identify compound 22 as 4-O-CSA.
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Table 1. TOF-MS and TOF-MS/MS data of compounds tentatively identified in F. sylvatica L. methanolic leaf extract. Compounds are numbered based on their retention time (RT) in the
total ion current chromatogram (RDB = Ring Double Bond equivalent value).








(ppm) RDB MS/MS Fragment Ions (m/z) and Relative Intensity
Benzoic and hydroxycinnamic acid derivatives
3 0.699 Hydroxycaffeoyl quinic acid C16H20O10 371.0984 371.0970 −3.7 7
371.1052(3.4); 353.0872(3.4); 341.0900(3.4); 191.0554(100);
173.0467(5.3); 135.0447(5.3)
4 0.875 Dihydroxybenzoic acid hexoside C13H16O9 315.0719 315.0722 −0.8 6.0
315.0714(18.8); 153.0191(16.0); 152.0112(60.5); 109.0294(34.8);
108.0217(100)
5 1.034 Hydroxybenzoic acid hexoside C13H1608 299.0772 299.0769 −1.1 6
299.0780(29.3); 239.0572(17.8); 179.0341(41.4); 137.0242(58.6);
136.0159(17.8); 121.0290(100); 93.0345 (41.4)
6 1.073 Dihydroxybenzoic acid C7H16O4 153.0193 153.0198 3.1 5 109.0291(100); 108.0215(87.5); 91.0185(12.4); 81.0341(8.7)
7 1.226 3-O-Caffeoyl quinic acid C16H18O9 353.0878 353.0893 0.8 8 191.0565(100); 179.0354(48.1); 135.0453(44.5); 134.0370(5.8)
8 1.495 Caffeoyl acid hexoside C15H18O9 341.0874 341.0878 −1.2 7
341.0886(9.4); 179.0339(22.0); 161.0244(100); 135.0444(9.4);
89.0243(18.6)
9 1.514 Caffeoyl threonic acid C13H14O8 297.0616 297.0613 −0.1 7 179.0344(9.6); 135.0304 (100); 117.0192 (6.6); 89.0246(11.6)
11 1.921 3-O-p-Coumaroyl quinic acid C16H18O8 337.0929 337.0921 −2.3 8 191.0550(61.4);173.0493(4.5);163.0396(100); 119.0946(74.6)
12 1.921 Caffeoyl quinic acid dimer C32H36O18 707.1829 707.1831 0.3 15
707.1845(100); 533.1307(2.3); 515.1192(3.8); 463.1085(3.5);
353.0870(8.2); 323.0546(3.2); 243.0651(2.6); 191.0557(32.1)
14 2.058 p-Coumaroyl acid hexoside C15H18O8 325.0929 325.0921 −2.4 7 163.0394(46.2); 119.0499(100)
16 2.370 5-O-Caffeoyl quinic acid C16H1809 353.0878 353.0878 0 8 191.0562(100); 85.0296(3.4)
17 3.048 Caffeoyl propionic acid C12H14O6 253.0718 253.0718 0.1 6
253.0726(19.0); 179.0347(19.0); 161.0241(100); 135.0454(63.4);
133.0295(70.8)
20 3.576 5-O-p-Coumaroyl quinic acid C16H18O8 337.0929 337.0918 −3.2 8
191.0560(100); 173.0442(4.0); 163.0405(6.0); 119.0491(6.7);
93.0346(16.9); 87.0073(3.7); 85.0290(2.7)
21 3.929 5-O-Caffeoyl shikimic acid C16H16O8 335.0772 335.0773 −0.4 9
335.0755(3.9); 179.0346(61.5); 173.0454(2.3); 161.0239(24.5);
135.0446(100); 134.0372(6.9); 93.0344(6.9)
22 4.047 4-O-Caffeoyl shikimic acid C16H16O8 335.0772 355.0768 −1.3 9 335.0748(3.9); 179.0350(21.5); 161.0237(100); 135.0449(22.7)
Flavonoids
13 1.921 Procyanidin (B type) C30H26O12 577.1352 577.1355 0.6 18
577.1366(22.0); 451.1030(14.9); 425.0863(27.3); 407.0772(100);
381.0998(12.6); 299.0523(11.1); 289.0710(79.4); 245.0444(18.5);
125.0240(79.4)
15 2.136 Catechin C15H14O6 289.0718 289.0708 −3.3 9
289.0696(38.3); 245.0818(30.8); 221.0797(30.8); 205.0505(15.0);
203.0709(54.1); 187.0381(30.8); 179.0365(23.3); 151.0403(40.6);
137.0246(30.8); 125.0238(30.8); 123.0447(84.2); 109.0290(100)
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(ppm) RDB MS/MS Fragment Ions (m/z) and Relative Intensity
18 3.048 Eriodictyol 7-O-hexoside C21H22O11 449.1089 449.1097 1.7 11
449.1097(2.5); 421.1142(8.5); 313.0717(2.5); 301.0709(9.4);
287.0553(33.9); 259.0609(100); 243.0661(8.2)
23 4.125 Kaempferol 3,7 di-O-hexoside C27H30O16 609.1461 609.1466 0.8 13
609.1517(100); 489.1064(25.2); 447.0941(82.9); 446.0886(49.6);
285.0390(82.9); 284.0300(25.2); 283.0241(28.1)
24 4.637 Naringenin 8-C-hexoside (1) C21H22O10 433.1140 433.1145 1.1 11
433.1165(7.1); 343.0830(34.3); 313.0724(100); 271.0616(15.9);
223.0251(6.7); 193.0142(24.0); 119.0503(5.4)
25 4.917 Naringenin 8-C-hexoside (2) C21H22O10 433.1140 433.1145 1.1 11
433.1146(6.2); 343.0819(30.6); 313.0714(100); 271.0603(14.8);
223.0243(5.6); 193.0136(24.3); 165.0817(4.8); 119.0501(9.1)
26 5.149 Myricetin 3-O-hexoside C21H20O13 479.0831 479.0844 12 2.7
479.0855(32.8); 317.0300(14.7); 316.0226(100); 287.0193(6.1);
271.0239(11.1)
27 5.772 Myricetin 3-O-pentoside C20H18O12 449.0725 449.0746 4.6 12
449.0728(26.4); 317.0287(7.5); 316.0216(100); 287.0183(10.5);
271.0241(18.4);
28 5.812 Kaempferol 3-O-dihexoside C27H30O16 609.1461 609.1481 3.3 13 609.1481(28.6); 285.0408(69.3); 284.0320(100); 255.0289(7.3)
30 6.046 Quercetin 3-O-hexoside C21H20O12 463.0882 463.0893 2.4 12
463.0902(21.1); 301.0352(60.3); 300.0274(100); 271.0246(28.6);
255.0292(15.9)
31 6.223 Quercetin 3-O-hexuronide C21H18O13 477.0675 477.0692 3.6 13
477.0694(5.5); 301.0354(100); 283.0237(2.5); 255.0295(2.3);
178.9974(6.3); 151.0029(6.2)
34 6.722 Naringenin 8-C-hexoside (3) C21H22O10 433.1140 433.1154 3.2 11
433.1144(3.1); 343.0822(34.7); 313.0715(100); 271.0600(19.4);
269.0818(3.9); 223.0235(7.0); 205.0127(3.0); 193.0141(31.8);
151.0039(7.1); 119.0501(10.8)
37 7.024 Isorhamnetin hexosyldeoxyhexoside C28H32O16 623.1618 623.1642 3.9 13
623.1636(100); 315.0501(11.1); 314.0423(70.7); 299.0176(15.2);
285.0423(5.4); 271.0256(5.4)
38 7.196 Quercetin 3-O-pentoside C20H18O11 433.0776 433.0795 4.3 12
433.0796(16.5); 301.0355(19.2); 300.0281(100); 271.0247(21.7);
255.0295(10.4)
39 7.240 Kaempferol3-O-galactopyranoside C21H20O11 447.0933 447.0946 2.9 12
447.0944(39.4); 327.0500(2.6); 285.0397(27.2); 284.0322(100);
255.0293(40.7); 227.0342(23.5)
41 8.003 Kaempferol 3-O-glucopyranoside C21H20O11 447.0933 447.0943 2.3 12
447.0943(35.5); 285.0398(55.2); 284.0322(100); 255.0295(47.0);
227.0345(27.7)
42 8.897 Kaempferol 3-O-pentoside C20H18010 417.0827 417.0844 4.0 12
417.0858(31.8); 285.0410(22.1); 284.0337(100); 255.0306(53.1);
227.0355(31.5)
43 9.203 Kaempferol (acetyl)-hexoside C23H22O12 489.1039 489.1054 3.2 13
489.1071(36.3); 285.0383(37.7);284.0313(100); 255.0307(28.4);
227.0329(12.3)
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44 10.260 Kaempferol 7-O-pentoside C20H18010 417.0827 417.0833 3.3 12
417.0833(38.1); 285.0398(100); 284.0330(85.6); 255.0301(52.1);
227.0355(38.1)
45 11.672 Kaempferol 7-O-deoxyhexoside C21H20O10 431.0984 431.0999 3.5 12
431.1006(24.2); 285.0407(100); 284.0328(87.5); 255.0299(44.6);
227.0349(20.6)
46 13.891 Kaempferol (acetyl)-pentoside C22H20O11 459.0933 459.0938 1.1 13
459.0970(60.6); 285.0395(10.4); 284.0331(100); 255.0304(36.7);
227.0350(26.1)
49 14.626 Kaempferolp-coumaroyl-hexoside (1) C30H26O13 593.1301 593.1326 4.3 18
593.1359(81.4); 447.0956(6.9); 285.0408(100); 284.0332(52.3);
255.0297(10.0); 227.0346(4.1)
50 14.747 Kaempferolp-coumaroyl-hexoside (2) C30H26O13 593.1301 593.1331 4.3 18
593.1349(100); 447.0958(9.1); 307.0820(6.2); 285.0404(97.7);
284.0313(57.1); 255.0288(9.3)
54 15.612 Kaempferol p-coumaroylPentoside C29H24O12 563.1195 563.1219 4.3 18 563.1230(69.8); 285.0406(100); 284.0316(52.3)
58 16.202 Luteolinp-coumaroyl-deoxyhexoside C30H26O12 577.1352 577.1378 4.6 18
577.1384(11.9); 431.1034(1.8); 284.0333(6.1); 285.0409(100);
283.0223(1.8); 257.0469(2.7); 229.0514(2.3)
68 18.075 Kaempferol di-p-coumaroyldeoxyhexoside C39H32O14 723.1719 723.1752 4.5 24




29 5.812 Isolariciresinol hexoside C26H34O11 521.2028 521.2046 3.4 10




isomer 1 C25H34O11 509.2028 509.2053 4.1 9
509.2044(16.9); 491.1926(13.3); 473.1824(27.9); 461.1813(25.9);
367.1395(53.6); 339.1450(6.2); 313.1290(98.3); 179.0712(100);
167.0711(7.2); 161.0611(12.4); 149.0608(27.6); 147.0445(13.3);
134.0373(8.9); 103.0405(8.0)
33 6.722 Cinchonain-Iisomer 1 C42H20O9 451.1035 451.1046 2.5 15
451.1083(9.6); 341.0669(100); 299.0551(27.9); 297.0762 (11.7);
281.0460(11.7);217.0131(7.5); 189.0186(15.0); 177.0185(18.2);
161.0246(6.4)
35 6.848 Cinchonain-Iisomer 2 C42H20O9 451.1035 451.1047 2.5 15
451.1056(6.3); 341.0674(100); 299.0593(4.7); 297.0762(6.4);
281.0451(12.5); 279.0652(4.7); 231.0288(6.3); 217.0136(9.3);
189.0178(12.5); 177.0193(12.5); 161.0246(4.7)
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36 6.888 Neolignan-9
′-O- rhamnoside
isomer 2 C25H34O11 509.2028 509.2051 4.4 9
509.2071(4.1); 491.1961(18.1); 473.1830(29.1); 461.1830(25.6);
458.1611(6.6); 367.1398(25.2); 313.1299(66.2); 179.0713(100);






C27H38O12 553.2304 553.2321 5.5 9







C27H38O12 551.2134 551.2167 6.0 10
551.2184(4.7); 533.2083(4.7); 343.1394(14.1); 328.1161(4.7);
209.0915(100); 194.0579(31.1); 176.0481(8.1)
Fatty acids
52 15.278 Trihydroxy-octadecadienoic acid C18H32O5 327.2177 327.2185 2.5 3
327.2187(88.3); 309.2087(3.0); 291.1962(16.4); 229.1448(51.1);
221.1183(15.4); 211.1341(100); 209.1186(7.9); 183.1385(27.6);
171.1026(33.2)
56 16.067 Hydroxyhexadecanoic acid C16H32O4 287.2228 287.2233 1.8 1 287.2236(100); 285.2077(7.2); 269.2114(8.8)
61 16.512 Dihydroxyoctadecedienoic quinicacid C25H42O9 485.2756 485.2780 4.9 5
485.2746(4.3); 311.2230(100); 293.2117(5.6); 275.2012(3.7);
223.1703(16.6); 191.0559 (87.9)
62 16.708 Linolenic acid derivative C31H38O6 505.2596 505.2589 −1.3 13 505.2605(37.2); 277.2176(100); 227.0323(5.2); 152.9955(9.2)
63 16.864 Hydroxyoctadecatrienoic acid C18H30O3 293.2122 293.2129 2.3 4
293.2111(65.6); 275.2014(82.9); 221.1539(59.0); 211.1338(25.2);
183.1385(100); 171.1016(50.3)
64 16.883 Linoleic acid derivative C34H44O9 595.2913 595.2915 0.4 13






C18H32O4 311.2228 311.2232 1.3 3
311.2238(39.4); 293.2125(12.6); 275.2017(9.9); 235.1710(11.1);
253.1804 (3.4); 223.1707(100); 183.0116(2.8)
66 17.738 Linolenic acidglyceryl-tetrahexoside C45H76O24 999.4654 999.4685 3.1 8
999.4751(100); 837.4302(2.0); 739.2582(12.1); 721.2452(29.1);
559.1919(3.4); 397.1370(4.0); 221.0682(1.3); 119.0353(1.3)
67 17.885 Linolenic acid derivative C32H41NO4 502.2963 502.2963 0.0 13 502.2958(17.3); 456.1546(6.3); 277.2175(100); 224.0689(6.3)
69 18.826 Linolenic acidglyceryl-dihexoside C33H56O4 675.3597 675.3629 4.7 6
675.3622(13.0); 415.1454(43.5); 397.1344(100); 379.1210(2.7);
305.0848(7.8); 277.2158(68.9); 253.0904(5.2); 235.0804(18.3),
179.0557(5.2); 161.0451(3.5); 119.0342(7.8); 89.0247(7.8)
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Other compounds
1 0.334 Quinic acid C7H12O6 191.0561 191.0561 −0.1 2
191.0565(6.7); 173.0455(5.3); 127.0404(15.0); 111.0459(7.9);
93.0356(60.7); 85.0305(100)
2 0.468 Tyrosine hexoside C15H21NO8 342.1194 342.1183 −3.3 6
252.0855(2.5); 222.0758(2.5); 191.0567(5.0); 180.0664(100);
119.0507(10.25)
10 1.670 Unknown C28H26O16 617.1148 617.1128 −3.3 16
617.1133(23.8); 455.0806(11.5); 319.0426(100); 297.0605(12.9);
259.0210(4.4); 215.0321(10.2); 201.0160(27.1); 179.0345(10.2);
135.0295(17.7)







C18H30O10 405.1766 405.1775 2.2 4
405.1775(11.4); 343.1799(5.6); 303.1548(5.6); 261.1311(8.6);
179.0545(17.0); 161.0461(14.2); 125.0237(45.7); 101.0240(65.5);
99.0451(100); 89.0246 (34.3)
51 15.240 Unknown C20H34O9 417.2130 417.2135 1.2 4
417.2147(51.9); 261.1345(44.5); 247.1190(36.1); 243.1268(3.6);
187.0977(100); 173.0821(94.2); 169.0865(11.1); 125.0973(46.1);
111.0818(46.1)
53 15.482 Unknown C38H52O16 763.3183 763.3207 3.2 13 763.3236(16.7); 343.1403(100); 328.1156(5.8)
55 15.912 Unknown C21H36O9 431.2287 431.2298 2.7 4
431.2307(26.5); 261.1346(36.6); 187.0976(100); 169.0868(10.3);
125.0972(40.8)
57 16.086 Unknown C21H36O9 431.2287 431.2299 2.9 4
431.2309(30.4); 261.1338(31.9); 187.0975(100); 169.0865(8.5);
125.0969(41.5)
59 16.261 Saponin isomer 1 C48H76O19 955.4908 955.4948 4.2 11 955.4990(100); 793.4449(6.8)
60 16.397 Saponin isomer 2 C48H76O19 955.4908 955.4941 4.1 11 955.4990(100); 793.4449(6.2)
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3.1.2. Flavonoids
Compounds 18, 24, 25, 34 were tentatively identified as flavanones. Compound 18
with the [M−H]− ion at m/z 449.1097 was tentatively identified as eriodictyol-7-O-hexoside.
In fact, the [M−H]− ion provided in the TOF-MS/MS experiment an abundant deproto-
nated aglycone ion (33.9%) at m/z 287.0553, following the neutral loss of a hexose moiety,
and the fragment ion at m/z 259.0609 (base peak) by neutral loss of CO (28 Da) and hexose
moiety (162.05 Da). Metabolites 24, 25 and 34 were hypothesized to be C-glycosylated
flavanones, which are much less studied than O-glycosides, but endowed with several
health benefits, such as antioxidant, anticancer, antitumor and anti-diabetic activities [33].
The occurrence of naringenin-C-glycosides was previously described by Hoffman et al. [25],
but though an HPLC-MS/MS via Multiple Reaction Monitoring (MRM) analysis was
performed, these authors did not provide sufficient MS/MS details to prove the presence
of these compounds in beech leaves. The almost superimposable MS/MS fragmentation
patterns were in accordance with naringenin C-hexoside isomers, likely bearing different
sugar moieties that reasonably explained the different retention times (Figure 3). In fact, the
deprotonated molecular ion at m/z 433.11 provided the ions [Ag+71]− at m/z 343.08 and
[Ag+41]− at m/z 313.07 (base peak) by the 0,2X and 0,3X cross-ring cleavage of hexoside,
likely linked at C-8 position. This hypothesis was supported by very low intensity of
dehydrated fragment ions at m/z 415.10 and 325.07, which are known to be much more
pronounced for 6-C isomers [34]. Although the occurrence of this kind of compounds
is quite unusual, some literature data consoled our hypothesis. Indeed, naringenin 8-
C-β-glucopyranoside (isohemiphloin) was isolated from Eucalyptus hemiphloia F. Muell.
(Myrtaceae), and its 6-C isomer (hemiphloin) was identified also in Ononis vaginalis M.Vahl.
(Fabaceae), Tulipa gesneriana L. and Ulmus wallichiana Planch., beside eriodictyol 6-C-β-D-
glucopyranoside [35].
Different flavan-3-ols mono- and diglycosides have been identified too. In Figure 4,
neutral losses and related molecular formulas of their main fragmentations are schema-
tized. In particular, considering flavonols group, monoglycosides were 82.2%, diglycosides
account 17.2%, and (acyl)-glycoside flavonols were only 0.51%. The deprotonated com-
pounds 26 (m/z 479.0844) and 27 (m/z 449.0746) were putatively identified as myricetin
3-O-hexoside and myricetin 3-O-pentoside, respectively. In fact, the loss of 162 Da (hexose
moiety) and 132 Da (pentose moiety) provided in both cases the fragment ion at m/z 317.02,
attributable to myricetin, together with its aglycone radical anion at m/z 316.02, whose
abundance allowed us to hypothesize the C-3 linkage of sugars moieties.
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the , metabolites 39 and 41 were pu atively identified as 3 O-galactopyranoside and
3-O-glucopyranoside derivatives. These latter were more abundant among kaempferol
derivatives, representing the 36.2%. The shorter retention time of the 3-O-galactopyranoside
derivative [36], the natural higher abundance of the 3-O-glucopyranoside isomer, and the
relative intensity of fragment ion at m/z 285 allowed us to discriminate the two isomers.
The mass spectrum of compound 42 was in accordance with kaempferol 3-O-pentoside.
In fact, MS/MS spectrum of the deprotonated molecular ion at m/z 417.0844 generated,
by neutral loss of 132 Da (dehydrated pentose moiety), the [M−H-C5H9O4]− ion at m/z
285.0410, whose corresponding radical aglycone ion at m/z 284.0337 was the peak base.
Instead, the neutral loss of 204.06 Da allowed us to tentatively identify metabolite 43 (at m/z
489.1054) as kaempferol (acetyl)-hexoside. Analogously, compound 46 at m/z 459.0938 was
putatively identified as kaempferol (acetyl)-pentoside, whose glycosidic bond cleavage
(−174.05 Da) provided a low aglycone ion and an abundant radical aglycone ion. Finally,
the different [aglycone-H]−/[aglycone-H]•− (m/z 285.0407/284.0328) ratio in the TOF-
MS2 spectrum of compound 45 was in accordance with a 7-O-deoxyhexosyl kaempferol,
whereas, among flavanol diglycosides, compounds 23 and 28, sharing the [M−H]− ion at
m/z 609.1466(81) and the same molecular formula (C27H30O16), were tentatively identified
as kaempferol dihexosides.
Compound 37 showed a TOF-MS/MS spectrum in accordance with isorhamnetin hex-
osyl deoxyhexoside. In fact, the break of 3-O-glycosidic cleavage, with a loss of 308.11 Da
(hexose+deoxyhexose), gave rise to the [aglycone-H]•− and [aglycone-H]− ions at m/z
314.0423 and 315.0501, respectively. A further loss of 15 Da, providing fragment ions at m/z
299.0176, supported the structural hypothesis. Metabolites 49, 50 and 68 were further iden-
tified as p-coumaroyl derivatives of kaempferol hexoside (49 and 50) and deoxyhexoside
(68). The [M−H]− ion at m/z 593.1326(31) of the compounds 49 and 50 led to [aglycone-
H]− and [aglycone-H]•− ions by neutral loss of 308.0951 Da and 309.1027 Da, in accordance
with a p-coumaroylhexosyl moiety. In the TOF-MS/MS spectra the neutral loss of 146.04 Da,
in accordance with the dehydrated p-coumaric acid, provided the ion at m/z 447.0954(8),
whose intensity allowed us to hypothesize the linkage of the hydroxycinnamic acid to
the saccharide moiety. Instead, metabolite 68, tentatively identified as kaempferol di-p-
coumaroyl deoxyhexoside, showed the [M−H]− ion at m/z 723.1752 that dissociated giving
fragment ions at m/z 577.1391 and 559.1232, according to neutral loss of dehydrated (or
not) p-coumaric acid. The fragment ion at m/z 437.1261 (48.6%) consisted in the acylated
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sugar moiety (di-p-coumaroyl-deoxyhexoside-H2O), according to the observed neutral
loss of 438.13 Da from deprotonated molecular ion that, through heterolytic or homolytic
cleavage, provided the ions at m/z 285.0404 and 284.0322. The deprotonated molecular
ion for compound 58 (at m/z 577.1378) was in accordance with a flavone acylglycoside,
likely luteolin p-coumaroyl-deoxyhexoside. In the TOF-MS/MS spectrum, the [M−H]− ion
dissociated supplying the abundant fragment ion [aglycone-H]− at m/z 285.0409, through
the neutral loss of 292.0975 Da (p-coumaric acid+deoxyhexose). The absence of fragment
ions at m/z 255 and m/z 227, which allowed flavonols to be distinguished from flavones,
allowed us to identify the aglycone as luteolin.
The fragmentation pattern of compound 13 was in accordance with the presence of
procyanidin (B-type). In fact, the [M−H]− ion at m/z 577.1355 dissociated losing the A-ring
of the flavanolic unit (−126 Da) through the heterocyclic ring fission (HRF) mechanism,
producing the fragment ion at m/z 451.1030. The fragment ion at m/z 425.0863 was due to
retro-Diels Alder (RDA) mechanism, and the monomeric unit at m/z 289.0710 was gener-
ated through the quinone methide fission [37]. Moreover, the deprotonated molecular ion
at m/z 289.0708 for compound 15 was in accordance with the molecular formula C15H14O6
and (epi)catechin compound. The decarboxylation (−44 Da) and subsequent loss of an
ethenone unit (C2H2O), generated fragment ions at m/z 245.0818 and 203.0709, respectively;
from the latter, the loss of lateral chain as 2-methylene-2H-pyran (C6H6O; −94.04 Da) for
nucleophilic attack of hydroxyl group to benzylic carbon, provided base peak at m/z
109.0290. Following the benzofuran-forming fission reaction from deprotonated molecular
ion the ion at m/z 123.0447 was formed [37].
3.1.3. Lignans
Compounds 29, 32, 36, and 47 were tentatively identified as lignans. In particular,
metabolite 29 was tentatively identified as isolariciresinol hexoside, whose deprotonated
molecular ion at m/z 521.2046 underwent neutral loss of sugar moiety providing the frag-
ment ion at m/z 359.1504, from which the loss of formaldehyde provided the abundant
ion at m/z 329.1396. Compounds 32 and 36 could be neolignan-O-deoxyhexoside iso-
mers; these metabolites were previously reported as unidentified compounds [11]. Instead,
two neolignan-9′-O-deoxyhexoside stereoisomers were isolated and identified by NMR
in Fagus hayatae Palib. ex Hayata lea [38]. This finding is in line with the occurrence
of these metabolites, which were also isolated in Pinus thunbergii [39]. Beside fragment
ions at m/z 491.1926(61) and 473.1824(30), which are derived from dehydration reactions,
the bond cleavage between the two phenylpropanoid units provided fragment ions at
m/z 179.0712(13) (base peak) and 313.1290(99). In Figure S2 TOF-MS/MS spectra were
reported, and the hypothesized chemical structures for the most abundant fragment ions
were provided.
The metabolite 47, whose tentative characterization was possible with a slight mod-
ification of Q-TOF parameters (Figure S3), was identified as 4,9,9′-trihydroxy-3,3′,5′-8-
O-4′-neolignan-7-O-deoxyhexoside [40]. The loss of 212.06 Da, likely corresponding to
trimethoxygallic acid, generated the fragment ion at m/z 343.1410, which in turn lost a
methyl radical to generate the ion at m/z 328.1177. The presence of the deoxyhexose moiety
was confirmed by loss of 146.06 Da, providing the ion at m/z 197.0821. As for compounds
32 and 36, the fragment ion derived by sugar loss has a very low intensity, likely justified
by an intramolecular hydrogen bond. Compound 48 with the [M−H]− ion at m/z 551.2167,
was supposed to be a lignan (Figure S4): 9′-hydroxy-7′-propen-3′,5′-dimethoxyphenyl-3-
methoxyphenyl-7,9-propanediol-4-O-hexoside [41]. The fragment ion at m/z 209.0815 was
attributable to a sinapyl alcohol moiety, from which ions at m/z 194.0579 and 179.0344
were generated. To the best of our knowledge, this lignan has never been identified in
F. sylvatica.
Flavolignan compounds, such as compounds 33 and 35 (at m/z 451.1047(46)) were
tentatively identified. These compounds were likely cinchonain-I isomers, which are
phenylpropanoid-substituted catechin, characterized by the ion at m/z 341.0669(74), gener-
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ated from the loss of the 3,4-dihydroxyphenyl group (−110 Da). Subsequently, through the
HRF mechanism and the RDA mechanism, the ions at m/z 189.0186(78) and 177.0185(93)
were formed, respectively.
3.1.4. Fatty Acids
The investigated extract also showed the occurrence of mono- or poly-hydroxylated
fatty acids, whose presence, together with epoxy derivatives, was previously identified
by Matzke et al. [42]. In particular, metabolite 52, was tentatively identified as trihydroxy
octadecadienoic acid (m/z 327.2185). It underwent dehydration processes, providing frag-
ment ions at m/z 309.2087 and 291.1962. The C12-C13 bond cleavage provided the ion at
m/z 229.1448, which in turn lost 58 Da (C3H6O) and 46 Da, to generate fragment ions at
m/z 183.1385 and 171.1026, respectively (Figure S5).
Compound 56 was putatively identified as hydroxyhexadecanoic acid, e.g., 16-OH-
hexadecanoic acid [33]), whose dehydration provided a low intensity ion at m/z 269.2114,
whereas TOF-MS/MS spectrum of compound 61 indicated it could be dihydroxyoctade-
cedienoyl quinic acid. The loss of dehydrated quinic acid, identified by fragment ion at
m/z 191.0559, produced an abundant ion at m/z 311.2230 that corresponded to the fatty
acid. In addition to fragment ions at m/z 293.2117 and 275.2012, obtained by losses of
hydroxy groups, also a fragment ion at m/z 223.1703, to cleavage between C-4 and C-5,
was detected (Figure S6).
Compound 63 was putatively a hydroxyoctadecatrienoic acid, maybe with hydroxyl
group at carbon C-10. In fact, the β-scission of the alcoholic group provided the ion [M−H-
110]− at m/z 183.1385 identified as base peak. An allyl scission provided ions at m/z
221.1539 and 211.1338 from dehydrated ion (m/z 275.2014) and deprotonated molecu-
lar ion, respectively. Compound 65 showed TOF-MS/MS spectrum in accordance with
15,16-dihydroxy-9,12-octadienoic acid [43]. Product ions deriving from water losses were
detected at m/z 293.2125 and 275.2017. Furthermore, allyl scission gave a low abundance
ion at m/z 253.1804, whereas the β-fission of the alcoholic hydroxyl group provided an
abundant ion at m/z 223.1707. Compound 69 (at m/z 675.3629) was putatively identified as
a linolenic acid glyceryl-dihexoside. In fact, the product ion at m/z 277.2158 corresponded
to the fatty acid moiety, whereas glyceryl dihexoside could be identified by fragment ions
at m/z 415.1454 and 397.1344; from the latter the loss of 92 Da, identifying a glycerol unit,
provided the ion at m/z 305.0848. In Figure S7, the TOF-MS/MS spectrum and a putative
fragmentation pathway are reported.
3.1.5. Other Minor Compounds
None of the remaining compounds were assignable to any of the previously discussed
classes. Briefly, compound 1 was likely quinic acid, whereas metabolite 2 was putatively
identified as tyrosine hexoside, based on the presence of the ion at m/z 180.0664 (deproto-
nated tyrosine), formed after the neutral loss of the hexose moiety. Metabolite 19 with the
[M−H]− ion at m/z 387.1666 was tentatively identified as 12-hydroxyjasmonate (tuberonic
acid) [18].
The TOF-MS/MS spectrum of compound 40 showed fragment ions at m/z 125.0237,
101.0240 and 99.0451 in accordance with a 3-hydroxy-3-methylglutaryl substitution of
hexenyl hexoside [44]. Thus, the metabolite was putatively a 3-hydroxy-3-methylglutaryl-
(O-hexenyl) hexoside, from which the loss of 144 Da (HMG) gave the fragment ion at
m/z 261.1311. Metabolites 59 and 60, with a [M−H]− ion at m/z 955.4948(41), were ten-
tatively identified as triterpenoid saponins with oleanolic acid as aglycone, previously
characterized in F. sylvatica leaves through spectroscopic techniques [13], but never by
mass spectrometry analysis. In order to obtain useful information about the fragmentation
pattern, declustering potential and collision energy values were optimized; thus, metabolite
59 was tentatively identified as 28-(D-glucopyranosyloxy)-28-oxoolean-12-en-3β-yl-3-O-(β-
D-glu-copyranosy1)-β-D-glucopyranosiduronic acid. The deprotonated molecular ion lost
the hexosyl moiety, providing the ion at m/z 793.4368(69), detected in TOF-MS/MS spectra
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of both metabolites, and underwent 0,2X cross-ring cleavage of hexuronic acid ring, to give
the ion at m/z 659.4152, diagnostic for the identification of metabolite 60 [13,45] (Figure S8).
The neutral loss of 176 Da (dehydrated hexuronic acid) from ion at m/z 631.38 provided
the ion at m/z 455.3505(16), most likely oleanolic acid.
3.2. Relative Quantitation of F. sylvatica Leaf Chemical Constituents
Hydroxycinnamic acid (HCA) derivatives constitute a considerable part of low molec-
ular weight phenol compounds. Caffeoyl-based HCA compounds were the most abundant,
as they account for 88.0% of the compounds with C6C1 and C6C3 carbon skeleton. In par-
ticular, chlorogenic acids, such as 3-O- and 5-O-caffeoyl quinic acid, were 27.9% and 54.9%,
respectively, whereas coumaroyl derivatives were less represented (~4.0%). The interest
in chlorogenic acids is due to the plethora of beneficial effect ascribed to these substances,
for which certain fruits, vegetables, spices are the main dietary sources. In particular,
5-O-caffeoyl quinic acid, firstly analyzed for its antioxidant, anti-inflammatory, and an-
titumor activity [46] was found to play multiple and key roles in protecting humans at
neuronal, cardiovascular, and gastrointestinal levels. It was also implied in glucose and
lipid metabolic regulation [47]. Besides caffeoyl derivatives, flavonoids appeared to be in
appreciable amount. Flavonols were the main constituents of this class, with a relative
percentage of 86.0%. Figure 5 shows the relative content of benzoic/hydroxycinnamic
acids class, and flavonoids.
Kaempferol derivatives were the most abundant (66.0%), followed by quercetin deriva-
tives (24.0%), and myricetin derivatives (10%). The abundance of flavonoids in different
organs of F. sylvatica, such as leaves or bark [12,48,49], was stated by different literature
data, in which kaempferol, quercetin, myricetin, luteolin or naringenin derivatives were
identified. Unusual naringenin-C-glycosides are as part of flavanone class, which is com-
monly associated to different benefits due to their ability to act as free radical-scavenger.
Juice and peel of citrus fruits are the main dietary sources of these compounds [50], which
were also clinically evaluated for cardiovascular disease protection. The anti-inflammatory,
antioxidant and soothing effects of flavonoids are broadly exploited for food, drugs or
cosmetics production [51].
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Apart from antiradical and reducing activities, food-derived flavonoids were shown
to prevent non-communicable diseases on-set, and to exert pro-oxidant effect in cancer
cells, thus increasing ROS levels and apoptosis rate. Several epidemiological evidences
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suggest that kaempferol-rich foods reduce the risk of liver, colon and skin cancer [52],
whereas the uncountable properties of quercetin and its derivatives give rise recently-filed
patents for disparate therapeutic applications [53]. Towards a green and sustainable waste
valorisation chain, the employment of F. sylvatica leaves should be pursued.
3.3. Beech Leaf Alcoholic Extract Showed Antioxidant Efficacy in Cell-Free Assays
The alcoholic leaf extract was evaluated for its antioxidant capability by means of
assays, involving stable radicals, such as DPPH• and ABTS•+ tests, and by ferricyanide
FRAP assay. Folin-Ciocalteu test, which employs phospho-tungsto-molybdate, was also
performed, together with the colorimetric determination of total flavonoid content. Data ac-
quired showed that the extract was effective in scavenging ABTS•+ with an ID50 and TEAC
value equal to 31.4± 1.10 µg/mL and 0.27, respectively, and it was able to markedly reduce
ferric ions, also at the lowest tested dose (Figure 6A). The total phenol content (TPC) was
69.64 ± 3.1 mg of gallic acid equivalents per g of extract (Figure 6B). Tanase et al. [24],
who investigated TPC in beech bark hydroalcoholic extract, found it was 76.49 mg GAE/g
plant material. Comparably, bark extracts of F. sylvatica, obtained by means of different ex-
tractive methods were screened for their antiradical activity and phenol content, and their
diversity in catechins, taxifolin glycosides, procyanidins, syringic acid or coniferyl alcohol
glycosides were further estimated by chromatographic techniques hyphenated to mass
spectrometry [10,24,48,54]. Among the few studies on beech leaf, a comparative qualitative
study was carried out on hydroalcoholic extracts (EtOH:water, 7:3, v/v) of beech leaves
collected in Romania; it was evidenced that TPC significantly varied based on leaf harvest
times [12,55], reaching the maximum TPC value (33.55 mg/g GAE), when leaves were col-
lected in September. According to UHPLC-ESI-QqTOF analysis, a high content of flavonoid
compounds was spectrophotometrically determined (Figure 6B).
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3.4. Beech Leaf Alcoholic Extract Decreased Intracellular ROS in Caco-2 Cells
The extract richness in polyphenols and the positive responses of cell-free antioxidant
tests paved the way to the evaluation of its antioxidant potential in cell-based assays. To this
purpose, Caco-2 cell line represents a useful model, able to predict in vivo behavior. In fact,
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besides being widely used as an in vitro model for the intestinal epithelial barrier, they were
reported to offer a distinctive advantage in screening intestinal absorption of natural
antioxidants after oral intake [21]. Thus, with the aim to exploit beech leaf phytochemicals
in the formulation of nutraceuticals, the ability of the extract to counteract reactive oxygen
species (ROS) overproduction was preliminarily evaluated in Caco-2 cells [49]. In fact,
metabolic activity is strongly related to ROS production, which intracellularly originate
in the mitochondrial respiratory chain, also producing toxic metabolic byproducts [56].
Thus, redox mitochondrial activity was first assessed by means of MTT test (Figure 7A).
The beech leaf alcoholic extract exhibited dose-response inhibition of the metabolic activity
of Caco-2 cells, with an ID50 equal to 148.4 µg/mL. In the cell model, after co-exposing
Caco-2 cell monolayer to increasing dose levels of the extract and to the fluorescent probe
DCFH-DA, oxidative stress is induced by 2,2-azobis(2-amidinopropane) dihydrochloride
(AAPH). Based on fluorescence levels, which are related to the oxidation degree, it was
observed that the extract markedly reduced the cellular fluorescence compared to the
untreated cells, when it was tested at dose level equal to 200 µg/mL (Figure 7B). The other
doses tested, while exhibiting less pronounced efficacy, showed a strongly time-dependent
activity. Overall, the dose-dependent capability of the beech leaf extract was ascertained.
Considering the cell basal rate in oxidizing species, the outcome of the investigated beech
on redox balance could be due to extract-induced mitochondrial alterations. The effect was
compared to that exerted by pure standard quercetin, which was tested at 10 µM, based on
cell viability data and according to literature [21,57]. In fact, the peroxyl radical scavenging
activity of quercetin in Caco-2 cells was broadly proved [21], and it was found that doses
of the flavonol higher than 20 µM markedly affected colon cells viability [57]
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4. Conclusions
Fagus sylvatica leaves, investigated through an untargeted UHPLC-HR-MS/MS analy-
sis, revealed their richness in flavonoids, mainly flavonol monoglycosides. Thus, the recov-
ery of this renewable plant source could favor an application to create beech leaf-derived
products, in the form of food or dietary supplements or herbal remedies for human or
animal health. Cell-free assays evaluating the antiradical and reducing capability, as well
as preliminary antioxidant capability in Caco-2 cells, strengthened this exploitation hy-
pothesis. Thus, the promising antioxidant results herein reported could be the basis for the
further phytochemical investigation of F. sylvatica, and the use of different extractive and
chromatographic approaches aimed at recovering high amounts of pure beech bioactive
compounds.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/antiox10071140/s1, Figure S1: Proposed fragmentation pathway for compound 12, Figure S2:
TOF-MS/MS spectra of the [M−H]− ions of compounds 32 (A) and 36 (B), tentatively identified as
neolignane-9′-O-deoxyhexoside are reported with the structures of different fragment ions tentatively
characterized. The proposed fragment pathway of much more abundant ions is also reported (C),
Figure S3: MS/MS spectral differences of the [M−H]− ions of compound 47 recorded at different
Q-TOF parameters: CE −75 V, CES 25 V and DP −90 V (A) or CE −35 V, CES 10 V and DP −70 V
(B). The proposed structures of more abundant ions are also reported, Figure S4: TOF-MS/MS
spectrum of compound 48, tentatively identified as 9′-hydroxy-7′-propen-3′,5′-dimethoxyphenyl-3-
methoxyphenyl-7,9-propanediol-4-O-hexoside and structures of different tentatively characterized
fragment ions, Figure S5: TOF-MS/MS spectrum of metabolite 52, tentatively identified as trihydroxy
octadecadienoic acid, whose hypothetical structure and fragmentation pathway was reported in
the grey box (the theoretical m/z value is reported below each structure), Figure S6: TOF-MS/MS
spectrum of metabolite 61, tentatively identified as dihydroxyoctadecedienoic quinic acid, Figure
S7: TOF-MS/MS spectrum of compound 69. The proposed fragmentation pathway of its [M−H]−
ion was reported in the grey box (the theoretical m/z value is reported below each structure),
Figure S8: TOF MS/MS spectra of the [M−H]− ions of metabolites 59 (A) and 60 (B); the proposed
chemical structures of fragment ions much more abundant are reported with different neutral losses.
The fragment ions detected only in one of two spectra are highlighted by red symbols.
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